GlassScriptPhysician profile
David Emanuel Richter
NPI 1821094954
$4,615.56
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,359 · 2020: $1,132 · 2021: $125.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $764.53 | 2019-2021 | |
| Pfizer INC. | $702.89 | 2019-2020 | |
| Abbvie INC. | $485.56 | 2019-2020 | |
| Janssen Biotech, INC. | $365.99 | 2019-2020 | |
| Genentech USA, INC. | $305.49 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $256.14 | 2019-2020 | |
| Glaxosmithkline, LLC. | $255.49 | 2019-2020 | |
| Lilly USA, LLC | $248.51 | 2019-2020 | |
| Ucb, INC. | $207.97 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $202.12 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $198.28 | 2019-2020 | |
| Radius Health, INC. | $191.63 | 2019-2020 | |
| Celgene Corporation | $86.03 | 2019 | |
| Pacira Therapeutics, INC. | $75.08 | 2019-2020 | |
| Mallinckrodt Hospital Products INC. | $63.58 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $52.59 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $40.25 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.79 | 2019 | |
| Sebela Pharmaceuticals INC. | $25.26 | 2019 | |
| Medexus Pharma, INC. | $17.68 | 2019 | |
| Alexion Pharmaceuticals, INC. | $16.68 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.15 | 2020 | |
| Horizon Therapeutics Plc | $11.87 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Richter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.